Next Article in Journal
Finite Element Simulation Study of Ultrasonic Vibration-Assisted Tensile High-Volume Fraction SiCp/Al Composite
Previous Article in Journal
Open-Cell Aluminum Foams by the Sponge Replication Technique
Open AccessArticle

Burst Release of Antibiotics Combined with Long-Term Release of Silver Targeting Implant-Associated Infections: Design, Characterization and in vitro Evaluation of Novel Implant Hybrid Surface

1
Department of Adhesive Bonding Technology and Surfaces, Fraunhofer Institute for Manufacturing Technology and Advanced Materials (IFAM), 28359 Bremen, Germany
2
Julius Wolff Institute, BIH Center for Regenerative Therapies, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 13353 Berlin, Germany
3
Experimental Trauma Surgery, Department of Trauma, Hand and Reconstructive Surgery, University Hospital Jena, 07747 Jena, Germany
4
Industrial and Environmental Biology, Hochschule Bremen-City University of Applied Sciences, Neustadswall 30, 28199 Bremen, Germany
*
Author to whom correspondence should be addressed.
Materials 2019, 12(23), 3838; https://doi.org/10.3390/ma12233838
Received: 30 September 2019 / Revised: 18 October 2019 / Accepted: 19 November 2019 / Published: 21 November 2019
Implant-associated infections represent a serious risk in human medicine and can lead to complications, revisions and in worst cases, amputations. To target these risks, the objective was to design a hybrid implant surface that allows a local burst release of antibiotics combined with long-term antimicrobial activity based on silver. The efficacy should be generated with simultaneous in vitro cytocompatibility. The investigations were performed on titanium K-wires and plates and gentamicin was selected as an illustrative antibiotic. A gentamicin depot (max 553 µg/cm2) was created on the surface using laser structuring. The antibiotic was released within 15 min in phosphate buffered saline (PBS) or agar medium. Metallic silver particles (4 µg/cm2) in a titanium dioxide layer were deposited using plasma vapor deposition (PVD). About 16% of the silver was released within 28 days in the agar medium. The local efficacy of the incorporated silver was demonstrated in a direct contact assay with a reduction of more than 99.99% (Escherichia coli). The local efficacy of the hybrid surface was confirmed in a zone of inhibition (ZOI) assay using Staphylococcus cohnii. The biocompatibility of the hybrid surface was proven using fibroblasts and osteoblasts as cell systems. The hybrid surface design seems to be promising as treatment of implant-associated infections, considering the achieved amount and release behavior of the active ingredients (gentamicin, silver). The generated in vitro results (efficacy, biocompatibility) proofed the concept. Further in vivo studies will be necessary translate the hybrid surface towards clinical applied research. View Full-Text
Keywords: implant-associated infection; silver; gentamicin; osseointegration; titanium; surface coating; orthopedics; release implant-associated infection; silver; gentamicin; osseointegration; titanium; surface coating; orthopedics; release
Show Figures

Figure 1

MDPI and ACS Style

Borcherding, K.; Marx, D.; Gätjen, L.; Bormann, N.; Wildemann, B.; Specht, U.; Salz, D.; Thiel, K.; Grunwald, I. Burst Release of Antibiotics Combined with Long-Term Release of Silver Targeting Implant-Associated Infections: Design, Characterization and in vitro Evaluation of Novel Implant Hybrid Surface. Materials 2019, 12, 3838.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop